NEW YORK: Axonius, a global leader in cyber asset intelligence, said Wednesday it acquired Cynerio, a specialist in medical device security, in a cash and stock transaction valued at more than $100 million.
The deal aims to eliminate the growing cybersecurity risks posed by connected medical devices in hospitals. These devices, critical to patient care, often operate outside the scope of traditional security tools, creating major vulnerabilities in healthcare networks.
“Hospitals have been operating with a massive digital security blind spot,” said Dean Sysman, Axonius co-founder and CEO. “From infusion pumps to MRI machines, these essential devices have remained invisible to cybersecurity teams. This acquisition will help end that.”
Sysman said merging Cynerio’s clinical expertise with Axonius’ asset intelligence would allow healthcare organizations to manage and protect their entire clinical environments with a unified platform.
Rasu Shrestha, MD, MBA, Chief Innovation and Commercialization Officer at Advocate Health and Chairman of the Board at Cynerio, called the acquisition a necessary shift in strategy.
“Risk doesn’t respect the boundaries between clinical and enterprise systems,” he said. “The combined technologies offer holistic visibility across all connected assets, helping providers build resilient security programs.”
Cynerio co-founders Leon Lerman and Daniel Brodie will join Axonius in senior roles as the company expands its healthcare footprint. Additional terms of the deal were not disclosed.